共 35 条
- [31] Emerging Therapies in Relapsed and Refractory Hodgkin Lymphoma: What Comes Next After Brentuximab Vedotin and PD-1 Inhibition? Current Hematologic Malignancy Reports, 2021, 16 : 1 - 7
- [33] Management of donation after brain death (DBD) in the ICU: the potential donor is identified, what's next? Intensive Care Medicine, 2019, 45 : 322 - 330